These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11277608)

  • 1. Hypericum perforatum (St John's Wort): a non-selective reuptake inhibitor? A review of the recent advances in its pharmacology.
    Nathan PJ
    J Psychopharmacol; 2001 Mar; 15(1):47-54. PubMed ID: 11277608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties.
    Barnes J; Anderson LA; Phillipson JD
    J Pharm Pharmacol; 2001 May; 53(5):583-600. PubMed ID: 11370698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of St John's wort in depression : what is known?
    Butterweck V
    CNS Drugs; 2003; 17(8):539-62. PubMed ID: 12775192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. St. John's wort: a new alternative for depression?
    Josey ES; Tackett RL
    Int J Clin Pharmacol Ther; 1999 Mar; 37(3):111-9. PubMed ID: 10190758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis.
    Ng QX; Venkatanarayanan N; Ho CY
    J Affect Disord; 2017 Mar; 210():211-221. PubMed ID: 28064110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of serotonergic antidepressants and St John's wort in older Australians: a population-based cohort study.
    Rahman SZ; Basilakis J; Rahmadi A; Lujic S; Musgrave I; Jorm L; Hay P; Münch G
    Australas Psychiatry; 2013 Jun; 21(3):262-6. PubMed ID: 23439542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the synaptosomal uptake inhibition of serotonin by St John's wort products.
    Schulte-Löbbert S; Holoubek G; Müller WE; Schubert-Zsilavecz M; Wurglics M
    J Pharm Pharmacol; 2004 Jun; 56(6):813-8. PubMed ID: 15231048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract.
    Cott JM
    Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():108-12. PubMed ID: 9342770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. St John's wort: Prozac from the plant kingdom.
    Di Carlo G; Borrelli F; Ernst E; Izzo AA
    Trends Pharmacol Sci; 2001 Jun; 22(6):292-7. PubMed ID: 11395157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current St John's wort research from mode of action to clinical efficacy.
    Müller WE
    Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1.
    Singer A; Wonnemann M; Müller WE
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1363-8. PubMed ID: 10454515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. St John's wort for depression: what's the evidence?
    Kelly BD
    Hosp Med; 2001 May; 62(5):274-6. PubMed ID: 11385886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The experimental and clinical pharmacology of St John's Wort (Hypericum perforatum L.).
    Nathan P
    Mol Psychiatry; 1999 Jul; 4(4):333-8. PubMed ID: 10483049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cellular and molecular effects of the antidepressant hyperforin on brain cells: Review of the literature].
    Bouron A; Lorrain E
    Encephale; 2014 Apr; 40(2):108-13. PubMed ID: 23816060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. St. John's wort extract Ze 117 (Hypericum perforatum) inhibits norepinephrine and serotonin uptake into rat brain slices and reduces 3-adrenoceptor numbers on cultured rat brain cells.
    Kientsch U; Bürgi S; Ruedeberg C; Probst S; Honegger UE
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S56-60. PubMed ID: 11518078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. About the cover: St. John's wort.
    J Soc Integr Oncol; 2006; 4(1):52-5. PubMed ID: 16737673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Hypericum perforatum (St. John's wort) on passive avoidance in the rat: evaluation of potential neurochemical mechanisms underlying its antidepressant activity.
    Misane I; Ogren SO
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S89-97. PubMed ID: 11518084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.
    Sacher J; Houle S; Parkes J; Rusjan P; Sagrati S; Wilson AA; Meyer JH
    J Psychiatry Neurosci; 2011 Nov; 36(6):375-82. PubMed ID: 21463543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Researching the antidepressant actions of Hypericum perforatum (St. John's wort) in animals and man.
    Franklin M; Cowen PJ
    Pharmacopsychiatry; 2001 Jul; 34 Suppl 1():S29-37. PubMed ID: 11518072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropharmacology of St. John's Wort (Hypericum).
    Bennett DA; Phun L; Polk JF; Voglino SA; Zlotnik V; Raffa RB
    Ann Pharmacother; 1998 Nov; 32(11):1201-8. PubMed ID: 9825087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.